Business UpdateMay 29, 2026, 04:08 PM
STERIS Reports Fiscal 2026 Business Update; Backlog up to $490.7M
AI Summary
STERIS plc filed its Annual Report on Form 10-K for the fiscal year ended March 31, 2026, detailing its operations across three reportable segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences, following the fiscal 2025 divestiture of its Dental segment. The company reported an increase in capital equipment backlog to $490.7 million at year-end, driven by shipment timing and acquisitions. The report also highlighted STERIS's commitment to ethical business practices, environmental conservation, and human capital management, including improved safety metrics and a diverse global workforce.
Key Highlights
- Divested Dental segment in fiscal 2025, now reported as discontinued operations.
- Capital equipment backlog increased to $490.7 million at March 31, 2026, from $452.9 million in fiscal 2025.
- Healthcare segment backlog reached $392.1 million at March 31, 2026.
- Life Sciences segment backlog was $98.7 million at March 31, 2026.
- Averaged 17,937 employees globally in fiscal 2026, up from 17,787 in fiscal 2025.
- Total Recordable Incident Rate (TRIR) improved to 1.03 in fiscal 2026 from 1.11.
- Lost-time Incident Rate (LTIR) improved to 0.32 in fiscal 2026 from 0.38.
- Held 606 US patents and 2,402 international patents as of March 31, 2026.
Price Impact
More from STE